CorMatrix ECM Technology has been used at more than 300 hospitals across the U.S. and has been implanted in nearly 20,000 cardiac procedures.
This naturally occurring extracellular matrix biomaterial supports native tissue repair by providing an interim bioscaffold, that enables a patient's own cells to repopulate and repair damaged tissues.


